Does radiotherapy have curative potential in metastatic patients? the concept of local therapy in oligometastatic breast cancer

Breast Care

Volumn 6, Issue 5, 2011, Pages 363-368

  Dellas, Kathrin ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Breast cancer; Oligometastases; Radiotherapy; Stereotactic body radiotherapy, SBRT

Indexed keywords

TAMOXIFEN;

BRAIN METASTASIS; BREAST CANCER; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CELL CLONE; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; HYPOTHESIS; IMAGE GUIDED RADIOTHERAPY; LIVER METASTASIS; LUNG METASTASIS; MOLECULAR BIOLOGY; NONHUMAN; OLIGOMETASTATIC BREAST CANCER; OLIGOMETASTATIC BREAT CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIOFREQUENCY ABLATION; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMIC THERAPY; TOXICITY;

EID: 84856920972     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000333115     Document Type: Review

References (48)

1. IARC (International Agency for Research on Cancer), Globocan 2008: www.dep.iarc.fr/globocan/globocan.html.
2. O'Shaughnessy J, Miles D, Vukelja S, Moiseyenko V, Ayoub JP, Cervantes G, Fumoleau P, Jones S, Lui WY, Mauriac L, Twelves C, Van Hazel G, Verma S, Leonard R: Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol 2002;20:2812-23. (Pubitemid 34651510)
3. Singletary SE, Walsh G, Vauthey JN, Curley S, Sawaya R, Weber KL, Meric F, Hortobágyi GN: A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 2003;8:241-51. (Pubitemid 36648810)
4. Holmes FA, Buzdar AU, Kau S-W, Fraschini G, Ames FC, McNeese MD, et al.: Combined-modality approach for patients with isolated recurrences of breast cancer (IV-NED) - the M. D. Anderson experience. Breast Dis 1994;7:7-20. (Pubitemid 24010824)
5. Hellman S, Weichselbaum RR: Oligometastases. J Clin Oncol 1995;13:8-10.
6. Hellman S, Weichselbaum RR: Importance of local control in an era of systemic therapy. Nat Clin Pract Oncol 2005;2:60-61. (Pubitemid 40790133)
7. Weichselbaum RR, Hellman S: Oligometastases revisited. Nat Rev Clin Oncol 2011;8:378-82.
8. Milano MT, Zhang H, Metcalfe SK, Muhs AG, Okunieff P: Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res Treat 2009;115:601-8.
9. Koong AC, Le QT, Ho A, Fong B, Fisher G, Cho C, Ford J, Poen J, Gibbs IC, Mehta VK, Kee S, Trueblood W, Yang G, Bastidas JA: Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2004;58:1017-21. (Pubitemid 38314781)
10. Tait CR, Waterworth A, Loncaster J, Horgan K, Dodwell D: The oligometastatic state in breast cancer: hypothesis or reality. Breast 2005;14:87-93. (Pubitemid 40353035)
11. Dunst J, Paulussen M, Juergens H: Lung irradiation for Ewing's sarcoma with pulmonary metastases at diagnosis: results of the CESS-studies. Strahlenther Onkol 1993;169:621-3. (Pubitemid 23327344)
12. Paulussen M, Ahrens S, Craft AW, Dunst J, Fröhlich B, Jabar S, Rübe C, Winkelmann W, Wissing S, Zoubek A, Jürgens H: Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients. J Clin Oncol 1998;16:3044-52. (Pubitemid 28417425)
13. Burdach S, van Kaick B, Laws HJ, Ahrens S, Haase R, Körholz D, Pape H, Dunst J, Kahn T, Willers R, Engel B, Dirksen U, Kramm C, Nürnberger W, Heyll A, Ladenstein R, Gadner H, Jürgens H, Go el U: Allogenic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria. Ann Oncol 2000;11:1451-62.
14. Meyers PA, Krailo MD, Ladanyi M, Chan KW, Sailer SL, Dickman PS, Baker DL, Davis JH, Gerbing RB, Grovas A, Herzog CE, Lindsley KL, Liu-Mares W, Nachman JB, Sieger L, Wadman J, Gorlick RG: High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for highrisk Ewing's sarcoma does not improve prognosis. J Clin Oncol 2001;19:2812-20. (Pubitemid 32538189)
15. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D'Angelica M: Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007;25:4575-80. (Pubitemid 350035315)
16. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, Maclean BJ, Foster JH, Daly JM, Fitzherbert D, et al.: Resection of the liver for colorectal carcinoma metastases: a multiinstitutional study of patterns of recurrence. Surgery 1986;100:278-84. (Pubitemid 16070861)
17. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D: Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer 1996;77:1254-62. (Pubitemid 26102322)
18. Cillo C, Dick JE, Ling V, Hill RP: Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines. Cancer Res 1987;47:2604-8. (Pubitemid 17083148)
19. Khodarev NN, Roach P, Pitroda SP, Golden DW, Bhayani M, Shao MY, Darga TE, Beveridge MG, Sood RF, Sutton HG, Beckett MA, Mauceri HJ, Posner MC, Weichselbaum RR: STAT1 pathway mediates amplification of metastatic potential and resistance to therapy. PLoS One 2009;4:e5821.
20. Nieto Y, Nawaz S, Jones RB, Shpall EJ, Cagnoni PJ, McSweeney PA, Barón A, Razook C, Matthes S, Bearman SI: Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer. J Clin Oncol 2002;20:707-18. (Pubitemid 34111378)
21. Bojko P, Welt A, Schleucher R, Borquez D, Scheulen ME, Vanhoefer U, Poettgen C, Stuschke M, Broelsch CE, Stamatis G, Wilke H, Seeber S, Harstrick A: High-dose chemotherapy with autologous stem cell transplantation in patients with oligometastatic breast cancer. Bone Marrow Transplant 2004;34:637-43. (Pubitemid 39341545)
22. Rades D, Fischer D, Veninga T, Stalpers LJ, Schild SE: Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer. Gynecol Oncol 2009;114:506-8.
23. Milano MT, Katz AW, Okunieff P: Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ. Am J Clin Oncol 2010;33:157-63.
24. Hortobagyi G, Piccart-Gebhart MJ: Current management of advanced breast cancer. Semin Oncol 1996;23(suppl 11):1-6.
25. Ben-Josef E, Lawrence TS: Using a bigger hammer: the role of stereotactic body radiotherapy in the management of oligometastases. J Clin Oncol 2009;27:1537-9.
26. Salama JK, Stenson KM, List MA, Mell LK, Maccracken E, Cohen EE, Blair E, Vokes EE, Haraf DJ: An initial report of a radiation doseescalation trial in patients with one to five sites of metastatic disease. Clin Cancer Res 2008;14:5255-9.
27. Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R, Cummings B, Ringash J, Tse RV, Knox JJ, Dawson LA: Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009;27:1585-91.
28. Macdermed, DM, Weichselbaum, RR and Salama, JK: A rationale for the targeted treatment of oligometastases with radiotherapy. J Surg Oncol 2008;98:202-6. Review.
29. Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, Timmerman R: Stereotactic body radiation therapy for early-stage non-small cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009;75:677-82.
30. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE: Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009;27:1572-8.
31. Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, Schefter TE: Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009;27:1579-84.
32. Brito RA, Valero V, Buzdar AU, Booser DJ, Ames F, Strom E, Ross M, Theriault RL, Frye D, Kau SW, Asmar L, McNeese M, Singletary SE, Hortobagyi GN: Long-term results of combined modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol 2001;19:628-33. (Pubitemid 32119077)
33. Wazer DE, Tercilla OF, Lin PS, Schmidt-Ullrich RK: Modulation in the radiosensitivity of MCF-7 human breast carcinoma cells by 17b-estradiol and tamoxifen. Br J Radiol 1989;62:1079-83. (Pubitemid 20025649)
34. Paulsen GH, Strickert T, Marthinsen AB, Lundgren S: Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro. Acta Oncol 1996;35:1011-9. (Pubitemid 27076974)
35. Kantorowitz DA, Thompson HJ, Furmanski P: Effect of conjoint administration of tamoxifen and high-dose radiation on the development of mammary carcinoma. Int J Radiat Oncol Biol Phys 1993;26:89-94. (Pubitemid 23137892)
36. Inano H, Onoda M, Suzuki K, Kobayashi H, Wakabayashi K: Prevention of radiation induced mammary tumours in rats by combined use ofWR-2721 and tamoxifen. Int J Radiat Biol 2000;76:1113-20. (Pubitemid 30488620)
37. Fisher B, Bryant J, Dignam JJ, Wickerham DL, Mamounas EP, Fisher ER, Margolese RG, Nesbitt L, Paik S, Pisansky TM, Wolmark N; National Surgical Adjuvant Breast and Bowel Project: Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002;20:4141-9. (Pubitemid 35191016)
38. Schmidberger H, Hermann RM, Hess CF, Emons G: Interactions between radiation and endocrine therapy in breast cancer. Endocr Relat Cancer 2003;10:375-88. (Pubitemid 37267556)
39. Lichtor AS: Three-dimensional conformal radiation therapy: a testable hypothesis. Int J Radiat Oncol Biol Phys 1991;21:853.
40. Leibel SA, Zelefsky MJ, Kutcher GJ, Burman CM, Mohan R, Mageras GS, Ling CC, Fuks Z: Threedimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase 1 dose escalation study. Semin Oncol 1994;21:580-97. Review.
41. Vijayakumar S, Myrianthopoulos LC, Rosenberg I, Halpern HJ, Low N, Chen GT: Optimization of radical radiotherapy with Beam's eye view techniques for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1991;21:779-88.
42. Carey Sampson M, Katz A, Constine LS: Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge? Semin Radiat Oncol 2006;16:67-76.
43. Kavanagh BD, McGarry RC, Timmerman RD: Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol 2006;16:77-84.
44. Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L: Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 2007;25:947-952. (Pubitemid 350002860)
45. Milano MT, Katz AW, Muhs AG, Philip A, Buchholz DJ, Schell MC, Okunieff P: A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 2008;112:650-8. (Pubitemid 351186206)
46. Milano MT, Zhang H, Metcalfe SK, Muhs AG, Okunieff P: Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res Treat 2009;115:601-8.
47. Milano MT, Katz AW, Schell MC, Philip A, Okunieff P: Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2008;72:1516-22.
48. Le Scodan R, Stevens D, Brain E, Floiras JL, Cohen-Solal C, De La Lande B, Tubiana-Hulin M, Yacoub S, Gutierrez M, Ali D, Gardner M, Moisson P, Villette S, Lerebours F, Munck JN, Labib A: Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy. J Clin Oncol 2009;27:1375-81.